ROLE OF RAB PROTEINS AND CA2+ IN VESICULAR TRANSPORT
RAB 蛋白和 CA2 在囊泡运输中的作用
基本信息
- 批准号:3300803
- 负责人:
- 金额:$ 28.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-07-01 至 1995-06-30
- 项目状态:已结题
- 来源:
- 关键词:Golgi apparatus adenosine triphosphate antiidiotype antibody calcium calcium binding protein cell membrane cold temperature electron microscopy endoplasmic reticulum enzyme linked immunosorbent assay guanine nucleotide binding protein guanosine triphosphate guanosinetriphosphatases immunoelectron microscopy intracellular transport protein engineering protein purification protein transport secretion site directed mutagenesis transport proteins vesicle /vacuole virus protein
项目摘要
We have developed a new model system to access directly intracellular
organelles of the eucaryotic cell. The plasma membrane of the eucaryotic
cell can be selectively perforated to produce semi-intact cells, a cell
population in which organelles of the secretory pathway (nucleus,
endoplasmic reticulum (ER), Golgi, and plasma membrane) are retained in an
intact, functional form and directly accessible to a wide range reagents
and macromolecules. It is the broad objective of the proposal to use this
model system to study in vitro the transport of protein between the ER and
the cis Golgi compartment. Transport of protein from the ER to the Golgi
occurs by the budding and fusion of carrier vesicles. Vesicle formation
requires ATP and as yet unspecified soluble and membrane-associated
components. Fusion of carrier vesicles to the Golgi compartment occurs
through a series of intermediate transport steps which require GTP
hydrolysis and Ca2+. We propose to specifically examine the role of the
rab gene family of synthesis of peptide reagents encoding functional
domains of the rab gene family. Peptides will be used as chemical analogs
to inhibit transport in order to elucidate rab protein function and to
prepare domain specific polyclonal and monoclonal antibodies to inhibit ER
to Golgi transport in vitro. These antibodies will be used as reagents to
study the role of low-molecular weight GTP binding proteins in ER to Golgi
transport and to identify potentially new members of this family. In
addition, recombinant rab protein will be prepared using both procaryotic
and eucaryotic expression vectors for analysis of the role of known rab
gene products in transport in vivo and in vitro. Site-directed binding,
hydrolysis and membrane-association in transport. We will also explore the
role of a newly discovered Ca2+-dependent step(s) in vesicular transport
which is likely to require novel Ca2+-binding protein(s) for vesicle fusion
to the Golgi compartment. These studies will include purification and
characterization of 3 sequential vesicular intermediates which accumulate
transported protein under 3 conditions: (1) reduced temperature
(15degreesC), (2) in the absence of GTP hydrolysis, and (3) in the absence
of free Ca2+. Many medically important diseases result from defects in
transport between intracellular organelles and the cell surface. These
include lysosomal storage diseases, familial hypercholesterolemia, cystic
fibrosis, and cancer. Establishing a model in vitro system for the study
of transport events occurring along the secretory pathway will have a major
impact on our understanding of the biochemistry of these diseases as a
result of understanding the basic mechanisms fundamental to trafficking of
protein between organelles of the eucaryotic cell.
我们开发了一种新的模型系统,
真核细胞的细胞器。 真核细胞的质膜
细胞可以被选择性地穿孔以产生半完整的细胞,
其中分泌途径的细胞器(细胞核,
内质网(ER),高尔基体和质膜)被保留在一个
完整、功能性形式,可直接接触各种试剂
和大分子。 该提案的总体目标是利用这一点,
模型系统,以在体外研究蛋白质在ER和
顺式高尔基体区室。 蛋白质从内质网向高尔基体的转运
通过载体囊泡的出芽和融合发生。 囊泡形成
需要ATP和尚未明确的可溶性和膜相关的
件. 载体囊泡融合到高尔基体
通过一系列需要GTP的中间运输步骤
水解和Ca2+。 我们建议具体研究
rab基因家族合成肽试剂的功能编码
RAB基因家族的结构域。 肽将被用作化学类似物
抑制转运以阐明RAB蛋白的功能,
制备结构域特异性的多克隆和单克隆抗体以抑制ER
高尔基体的运输。 这些抗体将被用作试剂,
研究ER中低分子量GTP结合蛋白对高尔基体的作用
运输和识别这个家庭的潜在新成员。 在
此外,重组rab蛋白将使用两种原核细胞制备。
和真核表达载体用于分析已知的rab
基因产物在体内和体外的运输。 定点结合,
运输中水解和膜结合。 我们亦会探讨
一个新发现的钙离子依赖步骤在囊泡转运中的作用
其可能需要新的Ca2+结合蛋白用于囊泡融合
到高尔基体 这些研究将包括纯化和
表征3个连续的囊泡中间体,
在3种条件下转运蛋白:(1)降低温度
(2)在没有GTP水解的情况下,和(3)在没有
游离Ca2+ 许多医学上重要的疾病是由于
细胞内细胞器和细胞表面之间的运输。 这些
包括溶酶体贮积病、家族性高胆固醇血症、囊性
纤维化和癌症。 建立研究的体外系统模型
发生在分泌途径上的运输事件的沿着将有一个主要的
影响了我们对这些疾病的生物化学的理解,
通过了解贩运人口的基本机制,
真核细胞的细胞器之间的蛋白质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Edward Balch其他文献
William Edward Balch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Edward Balch', 18)}}的其他基金
Applying Spatial Covariance to Understand Human Variation in Genetic Disease
应用空间协方差来了解遗传疾病的人类变异
- 批准号:
10734426 - 财政年份:2023
- 资助金额:
$ 28.94万 - 项目类别:
Using Genetic Diversity to Manage Neurological Disease
利用遗传多样性来治疗神经系统疾病
- 批准号:
10538562 - 财政年份:2021
- 资助金额:
$ 28.94万 - 项目类别:
Using Genetic Diversity to Manage Neurological Disease
利用遗传多样性来治疗神经系统疾病
- 批准号:
10321554 - 财政年份:2021
- 资助金额:
$ 28.94万 - 项目类别:
Using Genetic Diversity to Manage Neurological Disease
利用遗传多样性来治疗神经系统疾病
- 批准号:
10706236 - 财政年份:2021
- 资助金额:
$ 28.94万 - 项目类别:
相似海外基金
Adenosine triphosphate as a master variable for biomass in the oceanographic context
三磷酸腺苷作为海洋学背景下生物量的主变量
- 批准号:
2319114 - 财政年份:2023
- 资助金额:
$ 28.94万 - 项目类别:
Standard Grant
Characterizing the Interaction Between Adenosine Triphosphate and Pathological Alpha-synuclein Structures in Parkinson's Disease
表征帕金森病中三磷酸腺苷与病理性 α-突触核蛋白结构之间的相互作用
- 批准号:
565727-2021 - 财政年份:2021
- 资助金额:
$ 28.94万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Investigation of the development of pain during orthodontic tooth movement with adenosine triphosphate
三磷酸腺苷正畸牙齿移动过程中疼痛发生的研究
- 批准号:
20K18789 - 财政年份:2020
- 资助金额:
$ 28.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Neural Regulation of Adenosine Triphosphate (ATP) in the Nasal Mucosa
鼻粘膜三磷酸腺苷 (ATP) 的神经调节
- 批准号:
19K18793 - 财政年份:2019
- 资助金额:
$ 28.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Dynamics of the oxygen-dependent release of adenosine triphosphate from erythrocytes
红细胞氧依赖性三磷酸腺苷释放的动力学
- 批准号:
460605-2014 - 财政年份:2016
- 资助金额:
$ 28.94万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Development of an Analytical Tool Utilizing Electrochemical Detection Methods For the Measuring of Protein Kinase Activity on a Protein Substrate Using Ferrocene-Adenosine Triphosphate (Fc-ATP) as a C
利用电化学检测方法开发分析工具,以二茂铁-三磷酸腺苷 (Fc-ATP) 作为 C,测量蛋白质底物上的蛋白激酶活性
- 批准号:
469948-2014 - 财政年份:2016
- 资助金额:
$ 28.94万 - 项目类别:
Vanier Canada Graduate Scholarship Tri-Council - Doctoral 3 years
Adenosine Triphosphate as a Signal for Evaluating Microbial Risk from Groundwater Supplies
三磷酸腺苷作为评估地下水供应微生物风险的信号
- 批准号:
507411-2016 - 财政年份:2016
- 资助金额:
$ 28.94万 - 项目类别:
Engage Grants Program
Development of an Analytical Tool Utilizing Electrochemical Detection Methods For the Measuring of Protein Kinase Activity on a Protein Substrate Using Ferrocene-Adenosine Triphosphate (Fc-ATP) as a C
利用电化学检测方法开发分析工具,以二茂铁-三磷酸腺苷 (Fc-ATP) 作为 C,测量蛋白质底物上的蛋白激酶活性
- 批准号:
469948-2014 - 财政年份:2015
- 资助金额:
$ 28.94万 - 项目类别:
Vanier Canada Graduate Scholarship Tri-Council - Doctoral 3 years
Dynamics of the oxygen-dependent release of adenosine triphosphate from erythrocytes
红细胞氧依赖性三磷酸腺苷释放的动力学
- 批准号:
460605-2014 - 财政年份:2015
- 资助金额:
$ 28.94万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Dynamics of the oxygen-dependent release of adenosine triphosphate from erythrocytes
红细胞氧依赖性三磷酸腺苷释放的动力学
- 批准号:
460605-2014 - 财政年份:2014
- 资助金额:
$ 28.94万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral